Safety and tolerability of an injectable diagnostic radiopharmaceutical (68Ga-DOTATOC) in patients with proven gastro-entero-pancreatic neuroendocrine tumors

Update Il y a 4 ans
Reference: EUCTR2014-002741-21

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the safety and tolerability of a single administration of 2 MBq/kg - but not less than 100 MBq - of 68Ga-DOTATOC in patients suffering from gastro-entero-pancreatic neuroendocrine tumours.


Inclusion criteria

  • Patients with proven gastro-entero-pancreatic neuroendocrine tumours (GEP-NETs)

Links